P. Puri

ORCID: 0000-0002-5320-9647
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Esophageal and GI Pathology
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Urological Disorders and Treatments
  • Intestinal Malrotation and Obstruction Disorders
  • Congenital gastrointestinal and neural anomalies
  • Congenital Diaphragmatic Hernia Studies
  • Pediatric Urology and Nephrology Studies
  • Gastrointestinal disorders and treatments
  • Congenital Anomalies and Fetal Surgery
  • Organ Transplantation Techniques and Outcomes
  • Appendicitis Diagnosis and Management
  • Drug-Induced Hepatotoxicity and Protection
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gastroesophageal reflux and treatments
  • Clinical Nutrition and Gastroenterology
  • Urinary and Genital Oncology Studies
  • Infant Nutrition and Health
  • Tracheal and airway disorders
  • Intraperitoneal and Appendiceal Malignancies
  • Gallbladder and Bile Duct Disorders
  • Diverticular Disease and Complications
  • Pelvic floor disorders treatments

Fortis Healthcare
2024-2025

Regional Institute of Medical Sciences
2024

Fortis Escorts Hospital
2020-2023

Fortis Escorts Heart Institute
2020-2023

Command Hospital
2006-2021

Sir Ganga Ram Hospital
1996-2021

Max Healthcare
2021

Institute of Medical Sciences
2021

Synergy University
2021

Royal Derby Hospital
2016-2020

Morbidity and mortality attributable to chronic hepatitis C virus (HCV) infection are increasing in many countries as the infected population ages. Models were developed for 15 quantify characterize viremic population, well estimate number of new infections HCV related deaths from 2013 2030. Expert consensus was used determine current treatment levels outcomes each country. In most countries, prevalence has already peaked. every country studied, begins decline before 2030, when held...

10.1111/jvh.12351 article EN Journal of Viral Hepatitis 2015-01-01

Summary Chronic hepatitis C virus ( HCV ) infection is a leading cause of liver related morbidity and mortality. In many countries, there lack comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished expert consensus were used to determine key parameters, including prevalence, viremia, genotype the number patients diagnosed treated. this study 15 viremic prevalence ranged from...

10.1111/jvh.12350 article EN Journal of Viral Hepatitis 2015-01-01

The medical records of 116 consecutive cases congenital diaphragmatic hernia (CHD) among 368,772 live births at the three maternity hospitals in Dublin were examined and incidence associated malformations their impact on survival analysed. patients divided into two groups: group I included 64 (55%) who died during resuscitation stabilisation before surgery a mean age 11.2 hours II 52 (45%) operated upon. All underwent detailed postmortem examination as did 45% II. (SD) gestational for (36.1...

10.1136/adc.69.1_spec_no.68 article EN Archives of Disease in Childhood 1993-07-01

Hepatitis B infection during pregnancy can have serious consequences for both the mother and her infant. This study aimed to determine prevalence of hepatitis among pregnant women its effect on neonatal outcomes in a tertiary care hospital Pakistan. 120 were enrolled study, their demographic clinical data collected. The was 4.2% population. Infants born B-positive mothers more likely be premature low birth weight. Results showed that population 4.2%. However, timely vaccination significantly...

10.54112/bcsrj.v2023i1.282 article EN cc-by-nc Biological and Clinical Sciences Research Journal 2023-05-22

Hepatitis E virus (HEV) causes acute viral hepatitis and is endemic in the developing world. Few data are available on cellular immune responses HEV infection. Using flow cytometry, we studied frequencies of peripheral blood CD4+ /CD8+ T cells secreting interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-4 21 patients with 18 healthy controls, after stimulation capsid (ORF2) protein. Cytokine levels serum specimens culture supernatants ORF2-stimulated mononuclear (PBMCs) were...

10.1089/vim.2006.0053 article EN Viral Immunology 2007-03-01

Summary The hepatitis C virus ( HCV ) epidemic was forecasted through 2030 for 15 countries, and the relative impact of two scenarios considered: (i) increased treatment efficacy while holding treated population constant (ii) annual population. Increasing levels diagnosis treatment, in combination with improved efficacy, were critical achieving substantial reductions disease burden. In most had to increase several fold achieve largest ‐related morbidity mortality. This suggests that capacity...

10.1111/jvh.12352 article EN Journal of Viral Hepatitis 2015-01-01

Abstract Background and Aim The aim of this study was to analyze etiologies frequency hepatic extrahepatic organ failures (OFs) outcome acute‐on‐chronic liver failure (ACLF) at 10 tertiary centers in India. Methods In retrospective (2011–2014), patients satisfying Asian Pacific Association for the Study Liver definition ACLF were included. Etiology acute precipitating insult chronic disease outcomes assessed. Occurrence severity OF assessed by failure‐sequential assessment score. Results...

10.1111/jgh.13340 article EN Journal of Gastroenterology and Hepatology 2016-03-19

10.1016/s0022-3468(85)80006-3 article EN Journal of Pediatric Surgery 1985-12-01
Coming Soon ...